In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

A comprehensive review of clinical trials finds little convincing evidence that cannabis-based medicines provide real relief for chronic nerve pain.

Is marijuana getting too high on its own promises? New research published Monday adds to the evidence that medical cannabis ...

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART), according to new research from Texas Biomedical Research Institute. THC ...

Faced with chronic nerve pain, many people turn to cannabis-based medications, hoping for relief that conventional treatments ...

Combining low-dose THC and celecoxib improved cognition and reduced Alzheimer's-related brain pathology in mice. | Cannabis ...

In A Nutshell A mouse study found that low-dose THC combined with celecoxib protected memory and reduced brain damage linked ...

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated review ...

The two main compounds in cannabis are in a constant balancing act. This is an Inside Science story. (Inside Science) -- Many people who use cannabis do it for the euphoric effects caused by the main ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

National survey of more than 4,000 respondents showed that 15.6 per cent of Canadian adults were using the drug for slumber ...